AbbVie Inc. (ABBV) - 5i Research

AbbVie Inc. (ABBV $186.39)
- $186.39 Fwd P/E: 81.85X Cap: $335.40B
- View ABBV Profile
- View Questions on ABBV

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Apple Inc. (AAPL $209.11)
- $209.11 Fwd P/E: 32.5X Cap: $3.11T
- View AAPL Profile
- View Questions on AAPL
QUALCOMM Incorporated (QCOM $154.30)
- $154.30 Fwd P/E: 15.74X Cap: $169.41B
- View QCOM Profile
- View Questions on QCOM
AbbVie Inc. (ABBV $186.39)
- $186.39 Fwd P/E: 81.85X Cap: $335.40B
- View ABBV Profile
- View Questions on ABBV
Colgate-Palmolive Company (CL $88.15)
- $88.15 Fwd P/E: 25.17X Cap: $72B
- View CL Profile
- View Questions on CL
JPMorgan Chase & Co. (JPM $286.55)
- $286.55 Fwd P/E: 14.17X Cap: $802.32B
- View JPM Profile
- View Questions on JPM
Altria Group Inc. (MO $58.48)
- $58.48 Fwd P/E: 9.75X Cap: $97.91B
- View MO Profile
- View Questions on MO
Procter & Gamble Company (The) (PG $152.68)
- $152.68 Fwd P/E: 24.41X Cap: $360.49B
- View PG Profile
- View Questions on PG
Prudential Financial Inc. (PRU $102.98)
- $102.98 Fwd P/E: 16.64X Cap: $37.35B
- View PRU Profile
- View Questions on PRU
Williams Companies Inc. (The) (WMB $58.37)
- $58.37 Fwd P/E: 31.74X Cap: $72.08B
- View WMB Profile
- View Questions on WMB
ABM Industries Incorporated (ABM $47.89)
- $47.89 Fwd P/E: 39.59X Cap: $3.04B
- View ABM Profile
- View Questions on ABM
Berkshire Hathaway Inc. (BRK.B $470.13)
- $470.13 Fwd P/E: 12.69X Cap: $1.02T
- View BRK.B Profile
- View Questions on BRK.B
RTX Corporation (RTX $148.68)
- $148.68 Fwd P/E: 43.78X Cap: $199.43B
- View RTX Profile
- View Questions on RTX

Q: Hello 5i Team,

What are your top 12 more conservative or dividend-generating US stocks to buy in an RRSP for a 3-5 year hold?

Thanks in advance for your always helpful advice!

Read Answer Asked by Keith on July 14, 2025

Gilead Sciences Inc. (GILD $109.06)
- $109.06 Fwd P/E: 23.55X Cap: $139.43B
- View GILD Profile
- View Questions on GILD
Intuitive Surgical Inc. (ISRG $512.23)
- $512.23 Fwd P/E: 75.61X Cap: $183.53B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $186.39)
- $186.39 Fwd P/E: 81.85X Cap: $335.40B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $155.17)
- $155.17 Fwd P/E: 17.44X Cap: $377.32B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $771.75)
- $771.75 Fwd P/E: 65.04X Cap: $757.56B
- View LLY Profile
- View Questions on LLY
Medtronic plc. (MDT $89.22)
- $89.22 Fwd P/E: 24.86X Cap: $114.96B
- View MDT Profile
- View Questions on MDT
Stryker Corporation (SYK $390.59)
- $390.59 Fwd P/E: 52.9X Cap: $148.83B
- View SYK Profile
- View Questions on SYK
Thermo Fisher Scientific Inc (TMO $417.99)
- $417.99 Fwd P/E: 24.95X Cap: $160.56B
- View TMO Profile
- View Questions on TMO
Health Care Select Sector SPDR (XLV $132.60)
- $132.60 Fwd P/E: 65.56X Cap: $33.94B
- View XLV Profile
- View Questions on XLV
iShares U.S. Medical Devices ETF (IHI $60.76)
- $60.76 Fwd P/E: 105.73X Cap: $4.40B
- View IHI Profile
- View Questions on IHI
Sabra Health Care REIT Inc. (SBRA $18.41)
- $18.41 Fwd P/E: 31.58X Cap: $4.39B
- View SBRA Profile
- View Questions on SBRA
Healthcare Realty Trust Incorporated (HR $15.86)
- $15.86 Cap: $5.65B
- View HR Profile
- View Questions on HR
iShares U.S. Pharmaceuticals ETF (IHE $66.28)
- $66.28 Fwd P/E: 57.72X Cap: $567M
- View IHE Profile
- View Questions on IHE
Catalyst Pharmaceuticals Inc. (CPRX $20.95)
- $20.95 Fwd P/E: 13.77X Cap: $2.63B
- View CPRX Profile
- View Questions on CPRX

Q: There was an article in the Globe and Mail today by David Rosenberg about the aging population and he suggested health care related investments such as health care REITS, pharma, devices, and services. What do you think of this idea and can you give me a few recommendations in canada and the US for each of the 4 categories (health reits, pharma, devices, sefrvices)? A mix of ETFS and individual stocks would be great.

Read Answer Asked by Carla on July 08, 2025

Gilead Sciences Inc. (GILD $109.06)
- $109.06 Fwd P/E: 23.55X Cap: $139.43B
- View GILD Profile
- View Questions on GILD
Intuitive Surgical Inc. (ISRG $512.23)
- $512.23 Fwd P/E: 75.61X Cap: $183.53B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $186.39)
- $186.39 Fwd P/E: 81.85X Cap: $335.40B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $771.75)
- $771.75 Fwd P/E: 65.04X Cap: $757.56B
- View LLY Profile
- View Questions on LLY
Stryker Corporation (SYK $390.59)
- $390.59 Fwd P/E: 52.9X Cap: $148.83B
- View SYK Profile
- View Questions on SYK
Harvest Healthcare Leaders Income ETF (HHL $7.09)
- $7.09 Fwd P/E: 28.23X Cap: $1.12B
- View HHL Profile
- View Questions on HHL
Catalyst Pharmaceuticals Inc. (CPRX $20.95)
- $20.95 Fwd P/E: 13.77X Cap: $2.63B
- View CPRX Profile
- View Questions on CPRX

Q: Seems the whole Healthcare sector stocks are depressed right now. Aside from ISRG (owned) which five are the most compelling to own and at what entry price are they wotth it? Canadian would be best, or ADRs. But I'll take US or world suggestions also.
Thank you!

Read Answer Asked by Roger on June 27, 2025